TY - JOUR
T1 - Different effects of histamine H1 and H2 stimulation on left ventricular contractility in pigs
AU - Cooper, D. J.
AU - Schellenberg, R. R.
AU - Walley, K. R.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - Histamine decreases ventricular contractility in some settings but increases it in others. To better understand these apparently discrepant results, we measured hemodynamics and left ventricular pressure (Miller catheter) and volume (ultrasonic crystals) in atrially paced, α- and β- antagonist-treated pigs. Histamine was infused (0.5-10 μg · kg-1 · min- 1) before and after H2-antagonist (ranitidine) pretreatment. Changes in left ventricular contractile function were measured as shift of the end- systolic pressure-volume relationship (δESPVR) at a pressure of 100 mmHg. We found that at low doses (0.5 and 1 μg · kg-1 · min-1), histamine significantly decreased δESPVR (-1.1 ± 1.4 ml, P < 0.05) after H2- antagonist pretreatment. At doses above 1 μg · kg-1 · min-1, histamine increased contractility in a dose-response fashion [maximum effect: 5.1 ± 3.3 ml, dose resulting in 50% effect (ED50): 0.75 ± 1.79 μg · kg-1 · min-1] that was best described using a Hill coefficient of 2. Ranitidine increased the ED50 by approximately one order of magnitude (0.75 ± 1.79 to 9.50 ± 2.60 μg · kg-1 · min-1, P < 0.05). We conclude that in vivo, at higher doses, histamine increases left ventricular contractility via H2- receptor stimulation, whereas at low doses histamine decreases left ventricular contractility, probably via Hi-receptor stimulation.
AB - Histamine decreases ventricular contractility in some settings but increases it in others. To better understand these apparently discrepant results, we measured hemodynamics and left ventricular pressure (Miller catheter) and volume (ultrasonic crystals) in atrially paced, α- and β- antagonist-treated pigs. Histamine was infused (0.5-10 μg · kg-1 · min- 1) before and after H2-antagonist (ranitidine) pretreatment. Changes in left ventricular contractile function were measured as shift of the end- systolic pressure-volume relationship (δESPVR) at a pressure of 100 mmHg. We found that at low doses (0.5 and 1 μg · kg-1 · min-1), histamine significantly decreased δESPVR (-1.1 ± 1.4 ml, P < 0.05) after H2- antagonist pretreatment. At doses above 1 μg · kg-1 · min-1, histamine increased contractility in a dose-response fashion [maximum effect: 5.1 ± 3.3 ml, dose resulting in 50% effect (ED50): 0.75 ± 1.79 μg · kg-1 · min-1] that was best described using a Hill coefficient of 2. Ranitidine increased the ED50 by approximately one order of magnitude (0.75 ± 1.79 to 9.50 ± 2.60 μg · kg-1 · min-1, P < 0.05). We conclude that in vivo, at higher doses, histamine increases left ventricular contractility via H2- receptor stimulation, whereas at low doses histamine decreases left ventricular contractility, probably via Hi-receptor stimulation.
KW - end-systolic pressure-volume relationship
KW - H antagonist
UR - http://www.scopus.com/inward/record.url?scp=0029130627&partnerID=8YFLogxK
M3 - Article
C2 - 7573540
AN - SCOPUS:0029130627
SN - 0363-6135
VL - 269
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 3 38-3
ER -